In a decision that impacts how workers’ compensation insurers handle prescription drug claims, a 5-2 majority of the Pennsylvania Supreme Court ruled that a statutory ban on self-referrals does not prohibit physicians from directing injured workers to pharmacies in which the doctors hold a financial interest.
The decision in 700 Pharmacy vs. Bureau Of Workers’ Compensation Fee Review Hearing Office (State Workers’ Insurance Fund) carries significant implications for the workers’ compensation insurance industry, as medical cost containment and the management of escalating prescription drug expenses remain critical challenges for insurers, employers, and claims administrators.
The dispute originated when treating physicians prescribed medications to injured workers and directed them to fill these prescriptions at a specific pharmacy in which the prescribing doctors held a financial stake. The State Workers’ Insurance Fund (SWIF) challenged the subsequent billing, refusing payment on the grounds that these self-referrals violated the anti-referral clause of the workers’ compensation statute.
In the realm of workers’ compensation insurance, anti-referral laws and fee review processes are standard mechanisms utilized to control claim severity, the court noted. They are designed to prevent conflicts of interest that could lead to unnecessary medical treatments, overutilization of services, or inflated billing, all of which ultimately drive up insurance premiums.
The pharmacy argued that the specific language of Pennsylvania’s anti-referral statute lists right exact medical services—such as physical therapy, chiropractic care, and diagnostic imaging—but does not explicitly mention pharmacies or prescription drugs. Therefore, they contended that the restriction should not apply to their pharmaceutical dispensing, making them fully eligible for reimbursement from the insurance fund.
Conversely, SWIF argued that the phrase “goods and services” located at the end of the statute’s list acts as a broad catch-all category encompassing pharmaceuticals. The fund maintained that allowing doctors to profit from their own pharmacy referrals undermines the fundamental cost-containment goals of the workers’ compensation system and creates a financial incentive for physicians to overprescribe medications to injured workers.
In its analysis, the majority of the court strictly focused on the plain language and grammatical structure of the statute. The justices determined that the phrase “goods or services” does not stand alone as an independent, catchall category.
Instead, the court explained, “The proper reading of the Anti-Referral Provision’s plain language is that the phrase ‘goods or services’ modifies the enumerated medical services such that it is necessary to read ‘goods or services’ after each enumerated service.” The court reasoned that if the legislature had intended to ban self-referrals for absolutely all medical goods and services, listing the eight specific categories would have been entirely unnecessary.
Furthermore, the majority opinion highlighted that lawmakers explicitly addressed prescription drugs in a separate section of the law regarding reimbursement but deliberately omitted them from the anti-referral section, indicating a clear intent not to include them in the ban.
Ultimately, the Supreme Court reversed the lower court’s decision. The court concluded that the prohibition on provider self-referrals is strictly limited to the explicitly enumerated medical services. As a result, SWIF cannot use the anti-referral provision to deny payment to the pharmacy for the prescription drugs dispensed to the injured workers.
View the majority opinion here . &